Fanconi anemia proteins and their interacting partners: A molecular puzzle

Anemia

Volumn 2012, Issue , 2012, Pages

  Kaddar, Tagrid ^a,b   Carreau, Madeleine ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873840259     PISSN: 20901267     EISSN: 20901275     Source Type: Journal    
DOI: 10.1155/2012/425814     Document Type: Review

References (155)

1. Bagby G. C., Lipton J. M., Sloand E. M., Schiffer C. A., Marrow failure. Hematology 2004 318 336 2-s2.0-21644478225
2. Buchwald M., Carreau M., Schrezenmeier H., Bacigalupo A., Genetic basis of Fanconi anemia. Aplastic Anemia 1999 Cambridge, UK Cambridge University Press 403
3. Giampietro P. F., Verlander P. C., Davis J. G., Auerbach A. D., Diagnosis of Fanconi anemia in patients without congenital malformations: an international Fanconi anemia Registry Study. American Journal of Medical Genetics 1997 68 1 58 61 (Pubitemid 27023842)
4. Giampietro P. F., Adler-Brecher B., Verlander P. C., Pavlakis S. G., Davis J. G., Auerbach A. D., The need for more accurate and timely diagnosis in Fanconi anemia: a report from the international Fanconi anemia registry. Pediatrics 1993 91 6 1116 1120 2-s2.0-0027298257 (Pubitemid 23165787)
5. Tsilou E. T., Giri N., Weinstein S., Mueller C., Savage S. A., Alter B. P., Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology 2010 117 3 615 622 2-s2.0-77049088459 10.1016/j.ophtha.2009.08.023
6. Vale M. J., Dinis M. J., Bini-Antunes M., Porto B., Barbot J., Coutinho M. B., Audiologic abnormalities of Fanconi anaemia. Acta Oto-laryngologica 2008 128 9 992 996 2-s2.0-49649096099 10.1080/00016480701793750
7. Tischkowitz M., Dokal I., Fanconi anaemia and leukaemia-clinical and molecular aspects. British Journal of Haematology 2004 126 2 176 191 2-s2.0-3242658933 10.1111/j.1365-2141.2004.05023.x (Pubitemid 38961936)
8. Sari N., Akyuz C., Aktas D., Gumruk F., Orhan D., Alikasifoglu M., Aydin B., Alanay Y., Buyukpamukcu M., Wilms tumor, AML and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia. Pediatric Blood and Cancer 2009 53 2 208 210 2-s2.0-67649986712 10.1002/pbc.21966
9. Wajnrajch M. P., Gertner J. M., Huma Z., Popovic J., Lin K., Verlander P. C., Batish S. D., Giampietro P. F., Davis J. G., New M. I., Auerbach A. D., Evaluation of growth and hormonal status in patients referred to the international Fanconi anemia registry. Pediatrics 2001 107 4 I 744 754 2-s2.0-17744365737 10.1542/peds.107.4.744 (Pubitemid 32268460)
10. Giri N., Batista D. L., Alter B. P., Stratakis C. A., Endocrine abnormalities in patients with Fanconi anemia. Journal of Clinical Endocrinology and Metabolism 2007 92 7 2624 2631 2-s2.0-34447128814 10.1210/jc.2007-0135 (Pubitemid 47037367)
11. Kang M., Cancel all hollidays for SLX4 mutations: identification of a new Fanconi anemia subtype, FANCP. Clinical Genetics 2011 80 1 28 30 2-s2.0-79958141528 10.1111/j.1399-0004.2011.01679.x
12. Crossan G. P., Van Der Weyden L., Rosado I. V., Langevin F., Gaillard P. H. L., McIntyre R. E., Gallagher F., Kettunen M. I., Lewis D. Y., Brindle K., Arends M. J., Adams D. J., Patel K. J., Disruption of mouse SLX4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia. Nature Genetics 2011 43 2 147 152 2-s2.0-79251624412 10.1038/ng.752
13. Gallmeier E., Hucl T., Brody J. R., Dezentje D. A., Tahir K., Kasparkova J., Brabec V., Bachman K. E., Kern S. E., High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells. Cancer Research 2007 67 5 2169 2177 2-s2.0-33947213975 10.1158/0008-5472.CAN-06-2711 (Pubitemid 46424236)
14. De Winter J. P., Rooimans M. A., Van Der Weel L., Van Berkel C. G. M., Alon N., Bosnoyan-Collins L., De Groot J., Zhi Y., Waisfisz Q., Pronk J. C., Arwert F., Mathew C. G., Scheper R. J., Hoatlin M. E., Buchwald M., Joenje H., The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nature Genetics 2000 24 1 15 16 2-s2.0-0033989248 10.1038/71626 (Pubitemid 30041412)
15. Strathdee C. A., Gavish H., Shannon W. R., Buchwald M., Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992 356 6372 763 767 2-s2.0-0026521238 10.1038/356763a0
16. De Winter J. P., Waisfisz Q., Rooimans M. A., Van Berkel C. G. M., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J. C., Arwert F., Hoehn H., Digweed M., Buchwald M., Joenje H., The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nature Genetics 1998 20 3 281 283 2-s2.0-17344363009 10.1038/3093 (Pubitemid 28507674)
17. Foe J. R., Rooimans M. A., Bosnoyan-Collins L., Alon N., Wijker M., Parker L., Lightfoot J., Carreau M., Callen D. F., Savoia A., Cheng N. C., van Berkel C. G., Strunk M. H., Gille J. J., Pals G., Kruyt F. A., Pronk J. C., Arwert F., Buchwald M., Joenje H., Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nature genetics 1996 14 4 488 2-s2.0-0030341779
18. De Winter J. P., Leveille F., Van Berkel C. G. M., Rooimans M. A., Van der Weel L., Steltenpool J., Demuth I., Morgan N. V., Alon N., Bosnoyan-Collins L., Lightfoot J., Leegwater P. A., Waisfisz Q., Komatsu K., Arwert F., Pronk J. C., Mathew C. G., Digweed M., Buchwald M., Joenje H., Isolation of a cDNA representing the Fanconi anemia complementation group E gene. American Journal of Human Genetics 2000 67 5 1306 1308 2-s2.0-0033759693
19. Fanconi anaemia/Breast Cancer Consortium, Positional cloning of the Fanconi anaemia group A gene. Nature Genetics 1996 14 3 324 328
20. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., D'Andrea A. D., Moses R., GROMpe M., Positional cloning of a novel Fanconi anemia gene, FANCD2. Molecular Cell 2001 7 2 241 248 2-s2.0-17744394476 10.1016/S1097-2765(01)00172-1 (Pubitemid 32206492)
21. Howlett N. G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., GROMpe M., Joenje H., Pals G., Ikeda H., Fox E. A., D'Andrea A. D., Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002 297 5581 606 609 2-s2.0-18444362122 10.1126/science.1073834 (Pubitemid 34815345)
22. Meetei A. R., De Winter J. P., Medhurst A. L., Wallisch M., Waisfisz Q., Van de Vrugt H. J., Oostra A. B., Yan Z., Ling C., Bishop C. E., Hoatlin M. E., Joenje H., Wang W., A novel ubiquitin ligase is deficient in Fanconi anemia. Nature Genetics 2003 35 2 165 170 2-s2.0-0141484612 10.1038/ng1241 (Pubitemid 37187635)
23. Meetei A. R., Levitus M., Xue Y., Medhurst A. L., Zwaan M., Ling C., Rooimans M. A., Bier P., Hoatlin M., Pals G., De Winter J. P., Wang W., Joenje H., X-linked inheritance of Fanconi anemia complementation group B. Nature Genetics 2004 36 11 1219 1224 2-s2.0-10944239213 10.1038/ng1458
24. Levran O., Attwooll C., Henry R. T., Milton K. L., Neveling K., Rio P., Batish S. D., Kalb R., Velleuer E., Barral S., Ott J., Petrini J., Schindler D., Hanenberg H., Auerbach A. D., The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nature Genetics 2005 37 9 931 933 2-s2.0-25144497571 10.1038/ng1624 (Pubitemid 43086147)
25. Levitus M., Waisfisz Q., Godthelp B. C., De Vries Y., Hussain S., Wiegant W. W., Elghalbzouri-Maghrani E., Steltenpool J., Rooimans M. A., Pals G., Arwert F., Mathew C. G., Zdzienicka M. Z., Hiom K., De Winter J. P., Joenje H., The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nature Genetics 2005 37 9 934 935 2-s2.0-25144457604 10.1038/ng1625 (Pubitemid 43086148)
26. Bridge W. L., Vandenberg C. J., Franklin R. J., Hiom K., The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nature Genetics 2005 37 9 953 957 2-s2.0-25144503943 10.1038/ng1627 (Pubitemid 43086151)
27. Meetei A. R., Medhurst A. L., Ling C., Xue Y., Singh T. R., Bier P., Steltenpool J., Stone S., Dokal I., Mathew C. G., Hoatlin M., Joenje H., De Winter J. P., Wang W., A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nature Genetics 2005 37 9 958 963 2-s2.0-25144449181 10.1038/ng1626 (Pubitemid 43086152)
28. Pinto F. O., Leblanc T., Chamousset D., Roux G. L., Brethon B., Cassinat B., Larghero J., Villartay J. P. D., Stoppa-Lyonnet D., Baruchel A., Socié G., Gluckman E., Soulier J., Diagnosis of Fanconi anemia in patients with bone marrow failure. Haematologica 2009 94 4 487 495 2-s2.0-66349138262 10.3324/haematol.13592
29. Meindl A., Hellebrand H., Wiek C., Erven V., Wappenschmidt B., Niederacher D., Freund M., Lichtner P., Hartmann L., Schaal H., Ramser J., Honisch E., Kubisch C., Wichmann H. E., Kast K., Deiler H., Engel C., Müller-Myhsok B., Neveling K., Kiechle M., Mathew C. G., Schindler D., Schmutzler R. K., Hanenberg H., Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nature Genetics 2010 42 5 410 414 2-s2.0-77951720395 10.1038/ng.569
30. Vaz F., Hanenberg H., Schuster B., Barker K., Wiek C., Erven V., Neveling K., Endt D., Kesterton I., Autore F., Fraternali F., Freund M., Hartmann L., Grimwade D., Roberts R. G., Schaal H., Mohammed S., Rahman N., Schindler D., Mathew C. G., Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nature Genetics 2010 42 5 406 409 2-s2.0-77951747926 10.1038/ng.570
31. Auerbach A. D., Fanconi anemia and its diagnosis. Mutation Researchs 2009 668 1-2 4 10 2-s2.0-67650451108 10.1016/j.mrfmmm.2009.01.013
32. Kupfer G. M., Näf D., Suliman A., Pulsipher M., D'Andrea A. D., The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nature Genetics 1997 17 4 487 490 2-s2.0-0030667925 (Pubitemid 27518404)
33. De Winter J. P., Van Der Weel L., De Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R. J., Kruyt F. A. E., Hoatlin M. E., Joenje H., The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Human Molecular Genetics 2000 9 18 2665 2674 2-s2.0-0034326299
34. Garcia-Higuera I., Kuang Y., Näf D., Wasik J., D'Andrea A. D., Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Molecular and Cellular Biology 1999 19 7 4866 4873 2-s2.0-0033000911 (Pubitemid 29289525)
35. Medhurst A. L., Huber P. A. J., Waisfisz Q., De Winter J. P., Mathew C. G., Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Human Molecular Genetics 2001 10 4 423 429 2-s2.0-0035864856 (Pubitemid 32166553)
36. Garcia-Higuera I., Kuang Y., Denham J., D'Andrea A. D., The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 2000 96 9 3224 3230 2-s2.0-0034329325
37. Kruyt F. A. E., Abou-Zahr F., Mok H., Youssoufian H., Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain. Journal of Biological Chemistry 1999 274 48 34212 34218 2-s2.0-0033607530 10.1074/jbc.274.48.34212 (Pubitemid 129511759)
38. Waisfisz Q., De Winter J. P., Kruyt F. A. E., De Groot J., Van Der Weel L., Dijkmans L. M., Zhi Y., Arwert F., Scheper R. J., Youssoufian H., Hoatlin M. E., Joenje H., A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 10320 10325 2-s2.0-13044287347 10.1073/pnas.96.18.10320 (Pubitemid 29422556)
39. Ciccia A., Ling C., Coulthard R., Yan Z., Xue Y., Meetei A. R., Laghmani E. H., Joenje H., McDonald N., de Winter J. P., Wang W., West S. C., Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Molecular Cell 2007 25 3 331 343 2-s2.0-33846799430 10.1016/j.molcel.2007.01.003 (Pubitemid 46206138)
40. Ling C., Ishiai M., Ali A. M., Medhurst A. L., Neveling K., Kalb R., Yan Z., Xue Y., Oostra A. B., Auerbach A. D., Hoatlin M. E., Schindler D., Joenje H., De Winter J. P., Takata M., Meetei A. R., Wang W., FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO Journal 2007 26 8 2104 2114 2-s2.0-34247208998 10.1038/sj.emboj.7601666 (Pubitemid 46625801)
41. Singh T. R., Bakker S. T., Agarwal S., Jansen M., Grassman E., Godthelp B. C., Ali A. M., Du C. H., Rooimans M. A., Fan Q., Wahengbam K., Steltenpool J., Andreassen P. R., Williams D. A., Joenje H., De Winter J. P., Meetei A. R., Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. Blood 2009 114 1 174 180 2-s2.0-67650569540 10.1182/blood-2009-02-207811
42. Singh T. R., Saro D., Ali A. M., Zheng X. F., Du C. H., Killen M. W., Sachpatzidis A., Wahengbam K., Pierce A. J., Xiong Y., Sung P., Meetei A. R., MHF1-MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM. Molecular Cell 2010 37 6 879 886 2-s2.0-77949563363 10.1016/j.molcel.2010.01.036
43. Yan Z., Delannoy M., Ling C., Daee D., Osman F., Muniandy P. A., Shen X., Oostra A. B., Du H., Steltenpool J., Lin T., Schuster B., Décaillet C., Stasiak A., Stasiak A. Z., Stone S., Hoatlin M. E., Schindler D., Woodcock C. L., Joenje H., Sen R., de Winter J. P., Li L., Seidman M. M., Whitby M. C., Myung K., Constantinou A., Wang W., A histone-fold complex and FANCM forma conserved DNA-remodeling complex to maintain genome stability. Molecular Cell 2010 37 6 865 878 2-s2.0-77949701960 10.1016/j.molcel.2010.01.039
44. Tremblay C. S., Huang F. F., Habi O., Huard C. C., Godin C., Lévesque G., Carreau M., HES1 is a novel interactor of the Fanconi anemia core complex. Blood 2008 112 5 2062 2070 2-s2.0-52649092305 10.1182/blood-2008-04-152710
45. Thompson L. H., Hinz J. M., Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutation Research 2009 668 1-2 54 72 2-s2.0-67349107395 10.1016/j.mrfmmm.2009.02.003
46. Xue Y., Li Y., Guo R., Ling C., Wang W., FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Human Molecular Genetics 2008 17 11 1641 1652 2-s2.0-44349174992 10.1093/hmg/ddn054 (Pubitemid 351737168)
47. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M. S., Timmers C., Hejna J., GROMpe M., D'Andrea A. D., Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecular Cell 2001 7 2 249 262 2-s2.0-0035105291 10.1016/S1097-2765(01)00173-3 (Pubitemid 32206493)
48. Meetei A. R., Yan Z., Wang W., FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 2004 3 2 179 181 2-s2.0-2942664480 (Pubitemid 40268694)
49. Sims A. E., Spiteri E., Sims R. J., Arita A. G., Lach F. P., Landers T., Wurm M., Freund M., Neveling K., Hanenberg H., Auerbach A. D., Huang T. T., FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nature Structural and Molecular Biology 2007 14 6 564 567 2-s2.0-34249281152 10.1038/nsmb1252 (Pubitemid 46871814)
50. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald E. R., Hurov K. E., Luo J., Ballif B. A., Gygi S. P., Hofmann K., D'Andrea A. D., Elledge S. J., Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007 129 2 289 301 2-s2.0-34247110291 10.1016/j.cell.2007.03.009 (Pubitemid 46584733)
51. Nijman S. M. B., Huang T. T., Dirac A. M. G., Brummelkamp T. R., Kerkhoven R. M., D'Andrea A. D., Bernards R., The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Molecular Cell 2005 17 3 331 339 2-s2.0-13244291457 10.1016/j.molcel.2005.01.008 (Pubitemid 40193305)
52. Cohn M. A., Kowal P., Yang K., Haas W., Huang T. T., Gygi S. P., D'Andrea A. D., A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Molecular Cell 2007 28 5 786 797 2-s2.0-36749082959 10.1016/j.molcel.2007.09.031 (Pubitemid 350217060)
53. Yamashita T., Barber D. L., Zhu Y., Wu N., D'Andrea A. D., The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proceedings of the National Academy of Sciences of the United States of America 1994 91 14 6712 6716 2-s2.0-0028275031 10.1073/pnas.91.14.6712 (Pubitemid 24200732)
54. Youssoufian H., Localization of Fanconi anemia c protein to the cytoplasm of mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 1994 91 17 7975 7979 2-s2.0-0027999023 10.1073/pnas.91.17.7975 (Pubitemid 24253868)
55. Youssoufian H., Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. Journal of Clinical Investigation 1996 97 9 2003 2010 2-s2.0-0029863680
56. Hoatlin M. E., Christianson T. A., Keeble W. W., Hammond A. T., Zhi Y., Heinrich M. C., Tower P. A., Bagby G. C., The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood 1998 91 4 1418 1425 2-s2.0-0032520032 (Pubitemid 28086896)
57. Kruyt F. A. E., Youssoufian H., The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity. Blood 1998 92 7 2229 2236 2-s2.0-0032188916 (Pubitemid 28452962)
58. Yamashita T., Kupfer G. M., Naf D., Suliman A., Joenje H., Asano S., D'Andrea A. D., The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proceedings of the National Academy of Sciences of the United States of America 1998 95 22 13085 13090 2-s2.0-0032573229 10.1073/pnas.95.22.13085 (Pubitemid 28509528)
59. Eletto D., Dersh D., Argon Y., GRP94 in ER quality control and stress responses. Seminars in Cell and Developmental Biology 2010 21 5 479 485 2-s2.0-77952589171 10.1016/j.semcdb.2010.03.004
60. Hoshino T., Wang J., Devetten M. P., Iwata N., Kajigaya S., Wise R. J., Liu J. M., Youssoufian H., Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood 1998 91 11 4379 4386 2-s2.0-0032100480 (Pubitemid 28262004)
61. Kruyt F. A. E., Waisfisz Q., Dijkmans L. M., Hermsen M. A. J. A., Youssoufian H., Arwert F., Joenje H., Cytoplasmic localization of a functionally active Fanconi anemia group A-green fluorescent protein chimera in human 293 cells. Blood 1997 90 9 3288 3295 2-s2.0-0030735797 (Pubitemid 27473396)
62. Näf D., Kupfer G. M., Suliman A., Lambert K., D'Andrea A. D., Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization. Molecular and Cellular Biology 1998 18 10 5952 5960 2-s2.0-0031657241 (Pubitemid 28450546)
63. Kupfer G., Naf D., Garcia-Higuera I., Wasik J., Cheng A., Yamashita T., Tipping A., Morgan N., Mathew C. G., D'Andrea A. D., A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. Experimental Hematology 1999 27 4 587 593 2-s2.0-0032961359 10.1016/S0301-472X(99)00022-3 (Pubitemid 29181434)
64. Lightfoot J., Alon N., Bosnoyan-Collins L., Buchwald M., Characterization of regions functional in the nuclear localization of the Fanconi anemia group A protein. Human Molecular Genetics 1999 8 6 1007 1015 2-s2.0-0033047314 10.1093/hmg/8.6.1007 (Pubitemid 29250888)
65. Ferrer M., Rodríguez J. A., Spierings E. A., de Winter J. P., Giaccone G., Kruyt F. A. E., Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export. Human Molecular Genetics 2005 14 10 1271 1281 2-s2.0-19744367092 10.1093/hmg/ddi138 (Pubitemid 40744487)
66. Otsuki T., Kajigaya S., Ozawa K., Liu J. M., SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein. Biochemical and Biophysical Research Communications 1999 265 3 630 635 2-s2.0-0033619777 10.1006/bbrc.1999.1731
67. Thomashevski A., High A. A., Drozd M., Shabanowitz J., Hunt D. F., Grant P. A., Kupfer G. M., The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments. Journal of Biological Chemistry 2004 279 25 26201 26209 2-s2.0-2942735213 10.1074/jbc.M400091200 (Pubitemid 38798766)
68. Mukhopadhyay S. S., Leung K. S., Hicks M. J., Hastings P. J., Youssoufian H., Plon S. E., Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. Journal of Cell Biology 2006 175 2 225 235 2-s2.0-33750378214 10.1083/jcb.200607061 (Pubitemid 44631417)
69. Pace P., Johnson M., Tan W. M., Mosedale G., Sng C., Hoatlin M., De Winter J., Joenje H., Gergely F., Patel K. J., FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO Journal 2002 21 13 3414 3423 2-s2.0-18444384217 10.1093/emboj/cdf355 (Pubitemid 34760573)
70. Taniguchi T., D'Andrea A. D., The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 2002 100 7 2457 2462 2-s2.0-0036786873 10.1182/blood-2002-03-0860
71. Leveille F., Ferrer M., Medhurst A. L., Laghmani E. H., Rooimans M. A., Bier P., Steltenpool J., Titus T. A., Postlethwait J. H., Hoatlin M. E., Joenje H., de Winter J. P., The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC. DNA Repair 2006 5 5 556 565 2-s2.0-33646102474 10.1016/j.DNArep.2006.01.005
72. Leveille F., Blom E., Medhurst A. L., Bier P., Laghmani E. H., Johnson M., Rooimans M. A., Sobeck A., Waisfisz Q., Arwert F., Patel K. J., Hoatlin M. E., Joenje H., De Winter J. P., The Fanconi anemia gene product FANCF is a flexible adaptor protein. Journal of Biological Chemistry 2004 279 38 39421 39430 2-s2.0-4544355937 10.1074/jbc.M407034200 (Pubitemid 39258207)
73. Mi J., Kupfer G. M., The Fanconi anemia core complex associates with chromatin during S phase. Blood 2005 105 2 759 766 2-s2.0-11244337035 10.1182/blood-2004-01-0001 (Pubitemid 40070763)
74. Qiao F., Moss A., Kupfer G. M., Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. Journal of Biological Chemistry 2001 276 26 23391 23396 2-s2.0-0035968325 10.1074/jbc.M101855200
75. Akkari Y. M. N., Bateman R. L., Reifsteck C. A., Olson S. B., Grompe M., DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Molecular and Cellular Biology 2000 20 21 8283 8289 2-s2.0-0033780760 10.1128/MCB.20.21.8283-8289.2000
76. Garner E., Smogorzewska A., Ubiquitylation and the Fanconi anemia pathway. Febs Letters 2011 2-s2.0-79957542729 10.1016/j.febslet.2011.04.078
77. Alpi A. F., Patel K. J., Monoubiquitylation in the Fanconi anemia DNA damage response pathway. DNA Repair 2009 8 4 430 435 2-s2.0-63049094474 10.1016/j.DNArep.2009.01.019
78. Adachi D., Oda T., Yagasaki H., Nakasato K., Taniguchi T., D'Andrea A. D., Asano S., Yamashita T., Heterogenous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Human Molecular Genetics 2002 11 25 3125 3134 2-s2.0-0036900018 (Pubitemid 35439425)
79. Otsuki T., Nagashima T., Komatsu N., Kirito K., Furukawa Y., Kobayashi S. I., Liu J. M., Ozawa K., Phosphorylation of Fanconi anemia protein, FANCA, is regulated by akt kinase. Biochemical and Biophysical Research Communications 2002 291 3 628 634 2-s2.0-0036299024 10.1006/bbrc.2002.6504 (Pubitemid 34687392)
80. Collins N. B., Wilson J. B., Bush T., Thomashevski A., Roberts K. J., Jones N. J., Kupfer G. M., ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. Blood 2009 113 10 2181 2190 2-s2.0-64049107302 10.1182/blood-2008-05-154294
81. Yagasaki H., Adachi D., Oda T., Garcia-Higuera I., Tetteh N., D'Andrea A. D., Futaki M., Asano S., Yamashita T., A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA. Blood 2001 98 13 3650 3657 2-s2.0-0035895074 10.1182/blood.V98.13.3650
82. Otsuki T., Young D. B., Sasaki D. T., Pando M. P., Li J., Manning A., Hoekstra M., Hoatlin M. E., Mercurio F., Liu J. M., Fanconi anemia protein complex is a novel target of the IKK signalsome. Journal of Cellular Biochemistry 2002 86 4 613 623 2-s2.0-0036022114 10.1002/jcb.10270 (Pubitemid 34839963)
83. Mi J., Qiao F., Wilson J. B., High A. A., Schroeder M. J., Stukenberg P. T., Moss A., Shabanowitz J., Hunt D. F., Jones N. J., Kupfer G. M., FANCG is phosphorylated at serines 383 and 387 during mitosis. Molecular and Cellular Biology 2004 24 19 8576 8585 2-s2.0-4544253225 10.1128/MCB.24.19.8576-8585.2004 (Pubitemid 39245078)
84. Qiao F., Mi J., Wilson J. B., Zhi G., Bucheimer N. R., Jones N. J., Kupfer G. M., Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. Journal of Biological Chemistry 2004 279 44 46035 46045 2-s2.0-8544268704 10.1074/jbc.M408323200 (Pubitemid 39491597)
85. Futaki M., Watanabe S., Kajigaya S., Liu J. M., Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF- treatment. Biochemical and Biophysical Research Communications 2001 281 2 347 351 2-s2.0-0034813499 10.1006/bbrc.2001.4359 (Pubitemid 32928161)
86. Kupfer G. M., Yamashita T., Naf D., Suliman A., Asano S., D'Andrea A. D., The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 1997 90 3 1047 1054 2-s2.0-0030831350 (Pubitemid 27314139)
87. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P. R., Gregory R. C., Kim S. T., Lane W. S., Kastan M. B., D'Andrea A. D., Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002 109 4 459 472 2-s2.0-0037123768 10.1016/S0092-8674(02)00747-X (Pubitemid 34564473)
88. Ho G. P. H., Margossian S., Taniguchi T., D'Andrea A. D., Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Molecular and Cellular Biology 2006 26 18 7005 7015 2-s2.0-33748656748 10.1128/MCB.02018-05 (Pubitemid 44387648)
89. Zhi G., Wilson J. B., Chen X., Krause D. S., Xiao Y., Jones N. J., Kupfer G. M., Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for Fanconi anemia pathway function and BRCA2 interaction. Cancer Research 2009 69 22 8775 8783 2-s2.0-72249123144 10.1158/0008-5472.CAN-09-2312
90. Andreassen P. R., D'Andrea A. D., Taniguchi T., ATR couples FANCD2 monoubiquitination to the DNA-damage responsey. Genes and Development 2004 18 16 1958 1963 2-s2.0-4043133287 10.1101/gad.1196104 (Pubitemid 39071576)
91. Ishiai M., Kitao H., Smogorzewska A., Tomida J., Kinomura A., Uchida E., Saberi A., Kinoshita E., Kinoshita-Kikuta E., Koike T., Tashiro S., Elledge S. J., Takata M., FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nature Structural and Molecular Biology 2008 15 11 1138 1146 2-s2.0-55549137026 10.1038/nsmb.1504
92. Wang X., Kennedy R. D., Ray K., Stuckert P., Ellenberger T., D'Andrea A. D., Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Molecular and Cellular Biology 2007 27 8 3098 3108 2-s2.0-34047190253 10.1128/MCB.02357-06 (Pubitemid 46581321)
93. Kim J. M., Kee Y., Gurtan A., D'Andrea A. D., Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood 2008 111 10 5215 5222 2-s2.0-46749106037 10.1182/blood-2007-09-113092
94. Brodeur I., Goulet I., Tremblay C. S., Charbonneau C., Delisle M. C., Godin C., Huard C., Khandjian E. W., Buchwald M., Lévesque G., Carreau M., Regulation of the Fanconi anemia group C protein through proteolytic modification. Journal of Biological Chemistry 2004 279 6 4713 4720 2-s2.0-10744224928 10.1074/jbc.M301291200 (Pubitemid 38199065)
95. Park S. J., Beck B. D., Saadatzadeh M. R., Haneline L. S., Clapp D. W., Lee S. H., Fanconi anemia D2 protein is an apoptotic target mediated by caspases. Journal of Cellular Biochemistry 2011 112 9 2383 2391
96. Nordenson I., Effect of oxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with fanconi's anemia. Hereditas 1977 86 2 147 150 2-s2.0-0017652874 (Pubitemid 8224367)
97. Joenje H., Arwert F., Eriksson A. W., Oxygen-dependence of chromosomal aberrations in fanconi's anaemia. Nature 1981 290 5802 142 143 2-s2.0-0019444973 (Pubitemid 11149688)
98. Gille J. J. P., Wortelboer H. M., Joenje H., Antioxidant status of Fanconi anemia fibroblasts. Human Genetics 1987 77 1 28 31 2-s2.0-0023491236 (Pubitemid 18011237)
99. Korkina L. G., Samochatova E. V., Maschan A. A., Suslova T. B., Cheremisina Z. P., Afanas'ev I. B., Release of active oxygen radicals by leukocytes of Fanconi anemia patients. Journal of Leukocyte Biology 1992 52 3 357 362 2-s2.0-0026768965
100. Scarpa M., Rigo A., Momo F., Isacchi G., Novelli G., Dallapiccola B., Increased rate of superoxide ion generation in Fanconi anemia erythrocytes. Biochemical and Biophysical Research Communications 1985 130 1 127 132 (Pubitemid 15249009)
101. Degan P., Bonassi S., De Caterina M., Korkina L. G., Pinto L., Scopacasa F., Zatterale A., Calzone R., Pagano G., In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 1995 16 4 735 741 2-s2.0-0028987060
102. Ruppitsch W., Meißlitzer C., Hirsch-Kauffmann M., Schweiger M., Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. Febs Letters 1998 422 1 99 102 2-s2.0-0032559391 10.1016/S0014-5793(97)01608-6 (Pubitemid 28052874)
103. Nagasawa H., Little J. B., Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts. Carcinogenesis 1983 4 7 795 799 2-s2.0-0020961568 (Pubitemid 13010768)
104. Dallapiccola B., Porfirio B., Mokini V., Alimena G., Isacchi G., Gandini E., Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes. Human Genetics 1985 69 1 62 65 (Pubitemid 15153914)
105. Ruppitsch W., Meißlitzer C., Weirich-Schwaiger H., Klocker H., Scheidereit C., Schweiger M., Hirsch-Kauffmann M., The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Human Genetics 1997 99 6 710 719 2-s2.0-1842405395 10.1007/s004390050437 (Pubitemid 27243747)
106. Clarke A. A., Philpott N. J., Gordon-Smith E. C., Rutherford T. R., The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. British Journal of Haematology 1997 96 2 240 247 2-s2.0-0031039380 (Pubitemid 27077353)
107. Pearl-Yafe M., Halperin D., Halevy A., Kalir H., Bielorai B., Fabian I., An oxidative mechanism of interferon induced priming of the FAS pathway in Fanconi anemia cells. Biochemical Pharmacology 2003 65 5 833 842 2-s2.0-0037333837 10.1016/S0006-2952(02)01620-9 (Pubitemid 36293700)
108. Hadjur S., Jirik F. R., Increased sensitivity of FANCC-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. Blood 2003 101 10 3877 3884 2-s2.0-0038603197 10.1182/blood-2002-10-3147 (Pubitemid 36857862)
109. Saadatzadeh M. R., Bijangi-Vishehsaraei K., Hong P., Bergmann H., Haneline L. S., Oxidant hypersensitivity of Fanconi anemia type C-deficient cells is dependent on a redox-regulated apoptotic pathway. Journal of Biological Chemistry 2004 279 16 16805 16812 2-s2.0-1942533379 10.1074/jbc.M313721200 (Pubitemid 38509383)
110. Bijangi-Vishehsaraei K., Saadatzadeh M. R., Werne A., McKenzie K. A. W., Kapur R., Ichijo H., Haneline L. S., Enhanced TNF- -induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. Blood 2005 106 13 4124 4130 2-s2.0-28844482292 10.1182/blood-2005-05- 2096 (Pubitemid 41775917)
111. Hadjur S., Ung K., Wadsworth L., Dimmick J., Rajcan-Separovic E., Scott R. W., Buchwald M., Jirik F. R., Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding FANCC and Cu/Zn superoxide dismutase. Blood 2001 98 4 1003 1011 2-s2.0-0035883043 10.1182/blood.V98.4.1003
112. Reuter T. Y., Medhurst A. L., Waisfisz Q., Zhi Y., Herterich S., Hoehn H., Gross H. J., Joenje H., Hoatlin M. E., Mathew C. G., Huber P. A. J., Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Experimental Cell Research 2003 289 2 211 221 2-s2.0-0141788633 10.1016/S0014-4827(03)00261-1 (Pubitemid 37117407)
113. Cumming R. C., Lightfoot J., Beard K., Youssoufian H., O'brien P. J., Buchwald M., Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nature Medicine 2001 7 7 814 820 2-s2.0-0034927378 10.1038/89937 (Pubitemid 32691636)
114. Kruyt F. A. E., Hoshino T., Liu J. M., Joseph P., Jaiswal A. K., Youssoufian H., Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with ANDPH cytochrome P450 reductase. Blood 1998 92 9 3050 3056 2-s2.0-0032213353 (Pubitemid 28492309)
115. Futaki M., Igarashi T., Watanabe S., Kajigaya S., Tatsuguchi A., Wang J., Liu J. M., The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 2002 23 1 67 72 2-s2.0-0036195950 (Pubitemid 34213553)
116. Rathbun R. K., Faulkner G. R., Ostroski M. H., Christianson T. A., HugHES G., Jones G., Cahn R., Maziarz R., Royle G., Keeble W., Heinrich M. C., GROMpe M., Tower P. A., Bagby G. C., Inactivation of the Fanconi anemia group C gene augments interferon- γ-induced apoptotic responses in hematopoietic cells. Blood 1997 90 3 974 985 2-s2.0-0030845529 (Pubitemid 27314130)
117. Whitney M. A., Royle G., Low M. J., Kelly M. A., Axthelm M. K., Reifsteck C., Olson S., Braun R. E., Heinrich M. C., Rathbun R. K., Bagby G. C., Grompe M., Germ cell defects and hematopoietic hypersensitivity to γ -interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 1996 88 1
118. Segal G. M., Magenis R. E., Brown M., Keeble W., Smith T. D., Heinrich M. C., Bagby G. C., Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. Journal of Clinical Investigation 1994 94 2 846 852 2-s2.0-0027977842 (Pubitemid 24251019)
119. Cumming R. C., Liu J. M., Youssoufian H., Buchwald M., Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood 1996 88 12 4558 4567 2-s2.0-0029857336 (Pubitemid 26419138)
120. Kruyt F. A. E., Dijkmans L. M., Van Den Berg T. K., Joenje H., Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 1996 87 3 938 948 2-s2.0-0030063534
121. Marathi U. K., Howell S. R., Ashmun R. A., Brent T. P., The Fanconi anemia complementation group C protein corrects DNA interstrand cross-link-specific apoptosis in HSC536N cells. Blood 1996 88 6 2298 2305 2-s2.0-0029847786 (Pubitemid 26307934)
122. Haneline L. S., Broxmeyer H. E., Cooper S., Hangoc G., Carreau M., Buchwald M., Clapp D. W., Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from FAC(-/-) mice. Blood 1998 91 11 4092 4098 2-s2.0-0032101030 (Pubitemid 28261970)
123. Rosselli F., Sanceau J., Wietzerbin J., Moustacchi E., Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Human Genetics 1992 89 1 42 48
124. Schultz J. C., Shahidi N. T., Tumor necrosis factor- overproduction in Fanconi's anemia. American Journal of Hematology 1993 42 2 196 201 2-s2.0-0027513715 10.1002/ajh.2830420211 (Pubitemid 23062174)
125. Rosselli F., Sanceau J., Gluckman E., Wietzerbin J., Moustacchi E., Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. in vitro and in vivo spontaneous overproduction of tumor necrosis factor Blood 1994 83 5 1216 1225 2-s2.0-0028123475 (Pubitemid 24062844)
126. Wang J., Otsuki T., Youssoufian H., Lo Ten Foe J., Kim S., Devetten M., Yu J., Li Y., Dunn D., Liu J. M., Overexpression of the Fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis. Cancer Research 1998 58 16 3538 3541 2-s2.0-0032529624 (Pubitemid 28376546)
127. Koh P. S., Hughes G. C., Faulkner G. R., Keeble W. W., Bagby G. C., The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor- and fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily. Experimental Hematology 1999 27 1 1 8 2-s2.0-0033015745 10.1016/S0301-472X(98)00064-2 (Pubitemid 29123975)
128. Kurre P., Anandakumar P., Grompe M., Kiem H. P., In vivo administration of interferon gamma does not cause marrow aplasia in mice with a targeted disruption of FANCC. Experimental Hematology 2002 30 11 1257 1262 (Pubitemid 35287578)
129. Li X., Yang Y., Yuan J., Hong P., Freie B., Orazi A., Haneline L. S., Clapp D. W., Continuous in vivo infusion of interferon-gamma (IFN- γ) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in FANCC-/- mice. Blood 2004 104 4 1204 1209 2-s2.0-3843126410 10.1182/blood-2004-03-1094 (Pubitemid 39038045)
130. Li J., Sejas D. P., Zhang X., Qiu Y., Nattamai K. J., Rani R., Rathbun K. R., Geiger H., Williams D. A., Bagby G. C., Pang Q., Tnf- induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. Journal of Clinical Investigation 2007 117 11 3283 3295 2-s2.0-36048948219 10.1172/JCI31772 (Pubitemid 350096985)
131. Li Y., Youssoufian H., MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups. Journal of Clinical Investigation 1997 100 11 2873 2880 2-s2.0-0031438502 (Pubitemid 28007558)
132. Fagerlie S. R., Diaz J., Christianson T. A., McCartan K., Keeble W., Faulkner G. R., Bagby G. C., Functional correction of FA-C cells with FANCC suppresses the expression of interferon γ -inducible genes. Blood 2001 97 10 3017 3024 2-s2.0-0035874528 10.1182/blood.V97.10.3017
133. Pang Q., Fagerlie S., Christianson T. A., Keeble W., Faulkner G., Diaz J., Rathbun R. K., Bagby G. C., The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Molecular and Cellular Biology 2000 20 13 4724 4735 2-s2.0-0034130118 10.1128/MCB.20.13.4724-4735.2000 (Pubitemid 30396119)
134. + th cell subsets in FANCC-/- mice. Journal of Immunology 2004 173 6 3863 3870 2-s2.0-4644273869 (Pubitemid 39280749)
135. Castello G., Gallo C., Napolitano M., Ascierto P. A., Immunological phenotype analysis of patients with Fanconi's anaemia and their family members. Acta Haematologica 1998 100 1 39 43 2-s2.0-0031829644 10.1159/000040861 (Pubitemid 28360661)
136. Kaplan M. J., Sabio H., Wanebo H. J., Cantrell R. W., Squamous cell carcinoma in the immunosuppressed patient: fanconi's anemia. Laryngoscope 1985 95 7 I 771 775 2-s2.0-0021846151 (Pubitemid 15032766)
137. Froom P., Aghai E., Dobinsky J. B., Quitt M., Lahat N., Reduced natural killer activity in patients with Fanconi's anemia and in family members. Leukemia Research 1987 11 2 197 199 (Pubitemid 17014235)
138. Standen G. R., HugHES I. A., Geddes A. D., Jones B. M., Wardrop C. A. J., Myelodysplastic syndrome with trisomy 8 in an adolescent with Fanconi anaemia and selective IgA deficiency. American Journal of Hematology 1989 31 4 280 283 2-s2.0-0024338711 (Pubitemid 19188527)
139. Johansson E., Niemi K. M., Siimes M., Pyrhonen S., Fanconi's anemia. tumor-like warts, hyperpigmentation associated with deranged keratinocytes, and depressed cell-mediated immunity. Archives of Dermatology 1982 118 4 249 252 2-s2.0-0020038093 10.1001/archderm.118.4.249 (Pubitemid 12142605)
140. Pang Q., Keeble W., Christianson T. A., Faulkner G. R., Bagby G. C., FANCC interacts with Hsp70 to protect hematopoietic cells from IFN- γ /TNF- -mediated cytotoxicity. EMBO Journal 2001 20 16 4478 4489 2-s2.0-0035881864 10.1093/emboj/20.16.4478 (Pubitemid 32772042)
141. Melville M. W., Tan S. L., Wambach M., Song J., Morimoto R. I., Katze M. G., The cellular inhibitor of the PKR protein kinase, p58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity. Journal of Biological Chemistry 1999 274 6 3797 3803 2-s2.0-0033525168 10.1074/jbc.274.6.3797 (Pubitemid 29077228)
142. Pang Q., Keeble W., Diaz J., Christianson T. A., Fagerlie S., Rathbun K., Faulkner G. R., O'Dwyer M., Bagby G. C., Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon γ tumor necrosis factor- and double-stranded RNA. Blood 2001 97 6 1644 1652 2-s2.0-0035869495 10.1182/blood.V97.6.1644 (Pubitemid 32217229)
143. Pang Q., Christianson T. A., Keeble W., Koretsky T., Bagby G. C., The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. Journal of Biological Chemistry 2002 277 51 49638 49643 2-s2.0-0037147247 10.1074/jbc.M209386200 (Pubitemid 36014405)
144. Shifera A. S., Protein-protein interactions involving IKK γ (NEMO) that promote the activation of NF- B. Journal of Cellular Physiology 2010 223 3 558 561 2-s2.0-77951228086 10.1002/jcp.22105
145. Schmid J. A., Birbach A., I b kinase β (IKK β /IKK2/ikbkb)-a key molecule in signaling to the transcription factor NF- B. Cytokine and Growth factor Reviews 2008 19 2 157 165 2-s2.0-40749090052 10.1016/j.cytogfr.2008.01. 006 (Pubitemid 351382281)
146. + regulatory and natural killer-like T cells on signals leading to NF- B activation. Proceedings of the National Academy of Sciences of the United States of America 2004 101 13 4566 4571 2-s2.0-1842480966 10.1073/pnas.0400885101 (Pubitemid 38437451)
147. Hoatlin M. E., Yu Z., Ball H., Silvey K., Melnick A., Stone S., Arai S., Hawe N., Owen G., Zelent A., Licht J. D., A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 1999 94 11 3737 3747 2-s2.0-0345534801
148. Miaw S. C., Choi A., Yu E., Kishikawa H., Ho I. C., ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 2000 12 3 323 333 2-s2.0-0033696204
149. Piazza F., Costoya J. A., Merghoub T., Hobbs R. M., Pandolfi P. P., Disruption of PLZP in mice leads to increased T-lymphocyte proliferation, cytokine production, and altered hematopoietic stem cell homeostasis. Molecular and Cellular Biology 2004 24 23 10456 10469 2-s2.0-8644239397 10.1128/MCB.24.23.10456-10469.2004 (Pubitemid 39507882)
150. Lin W. C., Lai C. H., Tang C. J. C., Huang C. J., Tang T. K., Identification and gene structure of a novel human PLZF-related transcription factor gene, TZFP. Biochemical and Biophysical Research Communications 1999 264 3 789 795 2-s2.0-0033517820 10.1006/bbrc.1999.1594
151. Dai M. S., Chevallier N., Stone S., Heinrich M. C., McConnell M., Reuter T., Broxmeyer H. E., Licht J. D., Lu L., Hoatlin M. E., The effects of the Fanconi anemia zinc finger (FAZF) on cell cycle, apoptosis, and proliferation are differentiation stage-specific. Journal of Biological Chemistry 2002 277 29 26327 26334 2-s2.0-18544374874 10.1074/jbc.M201834200 (Pubitemid 34967124)
152. Li X., Plett P. A., Yang Y., Hong P., Freie B., Srour E. F., Orschell C. M., Clapp D. W., Haneline L. S., Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control. Blood 2003 102 6 2081 2084 2-s2.0-0141790934 10.1182/blood-2003-02-0536 (Pubitemid 37122383)
153. Tremblay C. S., Huard C. C., Huang F. F., Habi O., Bourdages V., Lévesque G., Carreau M., The Fanconi anemia core complex acts as a transcriptional co-regulator in hairy enhancer of split 1 signaling. Journal of Biological Chemistry 2009 284 20 13384 13395 2-s2.0-67649409202 10.1074/jbc.M807921200
154. Otsuki T., Furukawa Y., Ikeda K., Endo H., Yamashita T., Shinohara A., Iwamatsu A., Ozawa K., Liu J. M., Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Human Molecular Genetics 2001 10 23 2651 2660 2-s2.0-0035510108 (Pubitemid 33133406)
155. Trotter K. W., Archer T. K., The BRG1 transcriptional coregulator. Nuclear Receptor Signaling 2008 6 e004 2-s2.0-41649120828